Clinical Trials Browser

Breast Cancer Metastatic × trastuzumab deruxtecan × 30 days × Clear all

NCT06750484 2026-02-27

Trial of Trastuzumab Deruxtecan in Previously Treated HER2

Phase 2 Recruiting

Breast Cancer Metastatic